| 刘丹丽,邵喜英,罗 奇.乳腺癌患者化疗所致发热性中性粒细胞减少症的预防和治疗进展[J].中国肿瘤,2015,24(9):779-784. |
| 乳腺癌患者化疗所致发热性中性粒细胞减少症的预防和治疗进展 |
| Progress in Prevention and Treatment of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer |
| 投稿时间：2014-11-27 |
| DOI：10.11735/j.issn.1004-0242.2015.09.A015 |
|
 |
| 中文关键词: 乳腺癌 发热性中性粒细胞减少症 集落刺激因子 |
| 英文关键词:breast cancer febrile neutropenia colony stimulating factors |
| 基金项目:浙江省中医药重点研究项目（2015ZZ004） |
|
| 摘要点击次数: 2958 |
| 全文下载次数: 1142 |
| 中文摘要: |
| 摘 要：发热性中性粒细胞减少症是化疗所致的严重不良反应之一，使患者住院治疗周期延长，住院费用显著增加，同时影响化疗疗效。本文主要对乳腺癌患者化疗所致的发热性中性粒细胞减少症的风险评估、影响因素，以及集落刺激因子及抗菌药物的预防和治疗作一综述。 |
| 英文摘要: |
| Abstract：Febrile neutropenia was one of the most serious adverse reactions caused by chemotherapy，which extended the hospitalization period and significantly increased hospitalization expenses，reduced the efficacy of chemotherapy. This review focused on making a brief description and prospect of the risk evaluation，influence factors，prevention and treatment of colony stimulating factors and antibacterials of chemotherapy-induced febrile neutropenia in patients with breast cancer. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |